Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date  ▴ Location
Hey Life Sciences Fans, Remember The Deals Back in 2008… Ryan McBride 01/05/09 Boston
A Totally Cool $45M for Konarka, a $24M Boost for Momenta, IPO Woes for TransMedics and BioTrove, & More Boston-Area Deals News Rebecca Zacks 12/19/08 Boston
Seventh Sense Biosystems Raises $4.75M Series A, Board Attracts MIT’s Langer and Other Big Names Ryan McBride 12/17/08 Boston
Seventh Sense Biosystems Inc Receives $4,180,000 Series A Financing Round VentureDeal 12/16/08 Boston
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News Rebecca Zacks 11/26/08 Boston
Agios Pharmaceuticals Forges Ahead With Lab to Starve Cancer Cells Luke Timmerman 11/24/08 Boston
RXi Tackles RNAi Delivery, Pfizer Launches A Two-Cambridge Stem Cell Effort, Archemix Plows An Alternative Path to the Public Market, & More Boston-Area Life Sciences News Rebecca Zacks 11/20/08 Boston
Brightcove Bonds with Conde Nast, BSX Backs Brain-Implant Firm, $8 Million Shared With PeerApp, & More Boston-Area Deals News Rebecca Zacks 11/18/08 Boston
ZafGen Scores $14M Series B Rebecca Zacks 11/17/08 Boston
Zafgen, Inc. Lands $14,000,000 Series B Financing Round VentureDeal 11/17/08 Boston
A Trio of Tysabri Stories, Genzyme’s Big Deal with Osiris, A Peek Inside a Winning Hedge Fund, & More Life Sciences News Rebecca Zacks 11/05/08 Boston
Alnara Pharmaceuticals Aims to Make Biotech Drugs You Can Swallow, And That Go Right Where They Belong Luke Timmerman 10/30/08 Boston
Alnara Pharmaceuticals Inc Obtains $20,000,000 Series A Round VentureDeal 10/30/08 Boston
Sirtris Settles in at GSK, Alnylam Raises IP Questions on Bio Bill, Targanta Takes on Cubist’s Market, & More Life Sciences News Rebecca Zacks 09/24/08 Boston
Third Rock Ventures Heads “Back to the Basics,” Nurtures Disruptive Life Sciences Companies Luke Timmerman 09/23/08 Boston
Alnylam Adds Another RNA Approach, Vertex Tackles Hardest Hep C Cases, Zafgen Places Big Bet on Fat Shrinkers, & More Life Sciences News Rebecca Zacks 09/10/08 Boston
Zafgen, Developer of Fat-Shrinking Drugs, Hires Novartis Scientist as New CEO and Emerges From Stealth Mode Luke Timmerman 09/09/08 Boston
GT Solar Sees Brighter IPO Skies; Pfizer, Merck, and Eli Lilly Back Boston Startup; GSI Group Beams out $360M for Excel Technology & More Deals News Rebecca Zacks 07/14/08 Boston
Boston Scientific Wins Stent Approval, Resolvyx Moves Closer to Fish-Oil Drug Trials, Codon Cuts Algae Fuel Deal, & More Life Sciences News Rebecca Zacks 07/09/08 Boston
Agios, Developer of Drugs That Starve Cancer Cells, Scarfs Up $33 Million in Venture Funds Luke Timmerman 07/07/08 Boston
Agios Pharmaceuticals Lands $33,000,000 Series A Financing VentureDeal 07/07/08 Boston
Who Knew? Take 2: More Strange-But-True Details of Boston’s Innovation Leaders Robert Buderi 05/06/08 Boston
Mascoma Teams with GM, Moldflow Melds with Autodesk, Concert Scores Some Heavy-Duty Cash, & More Deals News Rebecca Zacks 05/05/08 Boston
ZS Genetics Enters the X Prize Fray, Biogen Falls on Rituxan News, Acusphere Takes a Step Toward Clinical Finish Line, & More Life Sciences News Rebecca Zacks 04/30/08 Boston
Constellation Off to a Stellar $32 Million Start, Helmed (For Now) By Ex Millennium Boss Erik Mellgren 04/29/08 Boston
Constellation Pharmaceuticals Secures $32,000,000 Series A Funding VentureDeal 04/29/08 Boston
What’s Ailing Personalized Medicine? Mark Levin Calls for Leadership at the Highest Level Malorye Allison 01/24/08 Boston
Third Rock Hires Three Partners—Says Team Complete to Implement Its Hands-On, Early-Stage Venture Model Robert Buderi 12/14/07 Boston
Bay State Led in Venture Funds Raised in First Three Quarters Robert Buderi 10/12/07 Boston
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.